Syra Health Corp. reports news as an integrated healthcare solutions company serving government, public-sector, and commercial healthcare organizations. Its updates center on prevention-focused and access-oriented solutions, including Population Health programs, healthcare analytics, HIPAA-compliant digital health tools, health education, training, and healthcare workforce solutions.
Recurring company developments include quarterly and annual financial results, margin and profitability trends, Population Health revenue growth, customer demand from state health departments and private-sector organizations, and cost-management initiatives. Syra Health also reports governance and leadership changes, information-security milestones such as ISO 27001:2022 certification, and operating risks tied to government healthcare budgets and contract timing.
Syra Health (SYRA) reported strong FY2025 results: population health revenue grew 157% to $5.3M and net loss narrowed 76% to ($896K) from ($3.8M). EPS improved to ($0.08) from ($0.50). Operating expenses declined 37% to $3.4M and gross margin rose to 34.4% from 20.7%.
The company ended 2025 with $1.6M cash, no long-term debt, launched new contracts and pilots, submitted Syrenity to FDA TEMPO, and expects profitability by year-end 2026.
Syra Health (OTCQB: SYRA) will report fourth quarter and full year 2025 financial results on Thursday, March 12, 2026. The company said it will release results via a press release before the market opens. Investors should monitor filings and the company website for the release.
Syra Health (OTCQB: SYRA) appointed Gregory R. Alexander as Chief Executive Officer, effective January 5, 2026. Alexander is a C-suite healthcare executive with 20+ years of P&L experience and prior roles across Medicare, Medicaid, population health, and healthcare technology.
Key disclosed credentials include expanding operations from three to 11 markets at Lumeris, growing Medicare Advantage membership by over 20% annually, tripling sales at CitizensRx, and overseeing operations with revenues from $45 million to $1.5 billion. Alexander is a Carmel, Indiana resident and former U.S. Marine Corps officer.
Syra Health (OTCQB: SYRA) reported third-quarter results for the period ended September 30, 2025, highlighting improved margins and reduced losses. Q3 revenue was $1.69M, driven by a 96% YoY increase in the Population Health segment to $1,280,011. Gross margin expanded 300 basis points to 33% and net loss narrowed 46% to ($225,902) versus Q3 2024. Adjusted EBITDA improved to ($218,601). Cash totaled $1.98M with no long-term debt. Management cited cost reductions (S&A down 12%, salaries and benefits down 43%) and a major commercial win: the SyraBot chatbot is live with a managed care organization serving 400,000 members.
Syra Health (OTCQB: SYRA) announced it will report financial results for the three months ended September 30, 2025 on Wednesday, November 12, 2025. The company said results will be released via press release before the market opens.
This notice provides the reporting date and timing for investors to review Syra Health's Q3 2025 financial results when published.
Syra Health (OTCQB: SYRA) reported Q2 2025 financial results showing progress toward profitability. Revenue remained steady at $1.9 million, with Population Health segment growing 197% to $1.6 million. The company achieved significant margin improvement, with gross margin expanding 2,090 basis points to 38.7% compared to Q2 2024.
Operating expenses decreased 53% to $816,000, while net loss improved dramatically to ($64,000) from ($1.4 million) in Q2 2024. EPS improved to ($0.01) from ($0.21). The company maintains a strong balance sheet with $2.3 million in cash and no long-term debt.
Notable developments include contract negotiations for a $5.8 million mental health program in Indiana and a new $2.1 million contract with a major health insurer, marking expansion into the private sector.
Syra Health (OTCQB: SYRA), a healthcare technology company, has scheduled the release of its Q2 2025 financial results for Tuesday, August 12, 2025. The company will publish its results for the three months ended June 30, 2025, via press release before the market opens.
The company, which focuses on developing innovative technology products and services for the healthcare sector, will provide detailed financial performance data in the upcoming announcement.Syra Health (OTCQB: SYRA) has secured a new one-year contract valued at up to $2.1 million with a major insurance provider. Under the agreement, Syra Health will provide medical management nurses to support specific health plans, working with healthcare providers and plan members.
The nurses will be responsible for assessing medical needs, interpreting benefits, and connecting members to appropriate care and support services. This contract expands Syra Health's existing services, which include data gathering and analysis for healthcare quality measures, by adding direct care support capabilities.
Syra Health (OTCQB: SYRA) has achieved ISO 27001:2022 certification, demonstrating its commitment to information security management. This certification is particularly significant for the company's AI-backed mental health app, Syrenity, which handles sensitive user data.
The certification validates Syra Health's comprehensive framework for managing information security risks and comes alongside the company's proprietary Syra Guardrails framework for ethical AI use in healthcare. The certification was granted following an independent audit of the company's security systems and procedures.
Syra Health (OTCQB: SYRA) has been selected for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site. The contract, valued at $5.8 million over three years with a possible one-year extension, involves Syra Health serving as the statewide access point for families and providers navigating Indiana's Child Mental Health Wraparound program.
The company has committed to subcontracting 23.5% of the total contract value to other Indiana-based companies. Revenue recognition is expected later in 2025 after final contract execution. The initiative aims to strengthen care coordination and improve mental health outcomes for children across Indiana, leveraging Syra Health's integrated approach combining public health expertise, data analytics, and mental health support.